Ethics and privacy considerations for systems biology applications in predictive and personalized medicine

Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications

Volumn , Issue , 2011, Pages 1-27

  Chen, Jake Y ^a,b,c   Xu, Heng ^d   Shi, Pan ^d   Culbertson, Adam ^b   Meslin, Eric M ^b,e  

^a Indiana Center for Systems Biology and Personalized Medicine   (United States)

^b INDIANA UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e Indiana University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054719896     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4018/978-1-60960-491-2.ch001     Document Type: Chapter

References (134)

1. Acquisti, A., & Grossklags, J. (2005). Privacy and Rationality in Individual Decision Making. IEEE Security & Privacy, 3(1), 26-33. doi:10.1109/MSP.2005.22
2. Aebersold, R., Auffray, C., Baney, E., Barillot, E., Brazma, A., & Brett, C. (2009). Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008). Molecular Oncology, 3(1), 9-17. doi:10.1016/j.molonc.2008.11.003
3. Anderlik, M. R., & Rothstein, M. A. (2001). Privacy and confidentiality of genetic information: what rules for the new science? Annual Review of Genomics and Human Genetics, 2(1), 401-433. doi:10.1146/annurev.genom.2.1.401
4. Andrews, L. B., Fullarton, J. E., Holtman, N. A., & Motulsky, A. G. (1994). Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press.
5. Angell, M. (2000). Is academic medicine for sale? The New England Journal of Medicine, 342(20), 1516-1518. doi:10.1056/NEJM200005183422009
6. Annas, G. J., Glantz, L. H., & Roche, P. A. (1995). Drafting the Genetic PrivacyAct: Science, Policy, and Practical Considerations. The Journal of Law, Medicine & Ethics, 23, 360. doi:10.1111/j.1748-720X.1995.tb01378.x
7. Anonymous,. (1966). Microfiche system saves time, cuts storage by 98 per cent. Modern Hospital, 107, 66-67.
8. ASHG. (1996). American Society of Human Genetics ASHG report: statement on informed consent for genetic research. American Journal of Human Genetics, 59, 471-474.
9. Ashworth, L., & Free, C. (2006). Marketing Dataveillance and Digital Privacy: Using Theories of Justice to Understand Consumers Online Privacy Concerns. Journal of Business Ethics, 67(2), 107-123. doi:10.1007/s10551-006-9007-7
10. Axler, R. E., Irvine, R., Lipworth, W., Morrell, B., & Kerridge, I. H. (2008).Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology, 75(6), 323-329. doi:10.1159/000164216
11. Baltimore, D. (2001). Our genome unveiled. Nature, 409(6822), 814-816. doi:10.1038/35057267
12. Barreiro, L. B., Henriques, R., & Mhlanga, M. M. (2009). High-throughput SNP genotyping: combining tag SNPs and molecular beacons. Methods in Molecular Biology (Clifton, N.J.), 578, 255-276. doi:10.1007/978-1-60327-411-1_17
13. Barrows, R. C., & Clayton, P. D. (1996). Privacy, Confidentiality, and Electronic Medical Records. Journal of the American Medical Informatics Association, 3(2), 139-148.
14. Bates, B. R., Lynch, J. A., & Bevan, J. L. (2005). Condit CM: Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Social Science &Medicine, 60, 331-344. doi:10.1016/j.socscimed.2004.05.012
15. Bennett, C. J. (1995). The Political Economy of Privacy: A Review of the Literature. Hackensack, NJ: Center for Social and Legal Research.
16. Bernhardt, B. A., Tambor, E. S., Fraser, G., Wissow, L. S., & Geller, G. (2002). Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: Implications for informed consent. American Journal of Medical Genetics, 116A(4), 315-323. doi:10.1002/ajmg.a.10040
17. Beskow, L. M., Burke, W., Merz, J. F., Barr, P. A., &Terry, S., V.B., P., et al. (2001). Informed consent for population-based research involving genetics. Journal of the American Medical Association, 286, 2315-2321. doi:10.1001/jama.286.18.2315
18. Bok, S. (1989). Secrets: On the Ethics of Concealment and Revelation. New York: Vintage.
19. Brown, S. M. (2002). Essentials of Medical Genomics. Hoboken, NJ: John Wiley & Sons, Inc. doi:10.1002/0471483087
20. Bruse, S., Moreau, M., Azaro, M., Zimmerman, R., & Brzustowicz, L. (2008). Improvements to bead-based oligonucleotide ligation SNP genotyping assays. BioTechniques, 45(5), 559-571. doi:10.2144/000112960
21. Bui, C.T., Babon, J.J., Lambrinakos, A., & Cotton, R.G. (2003). Detection of mutations in DNA by solid-phase chemical cleavage method. Asimplified assay. Methods in Molecular Biology (Clifton, N.J.), 212, 59-70.
22. Camp, L. J. (1999). Web security and privacy: An American perspective. [Article]. The Information Society, 15(4), 249-256. doi:10.1080/019722499128411
23. Campbell, A. V. (2007). The ethical challenges of genetic databases: safeguarding altruism and trust. King's Law Journal, 18, 227-246.
24. Caplan, A. L. (2009). What No One Knows Cannot Hurt You: The Limits of Informed Consent in the EmergingWorld of Biobanking. In Solbakk, J. H., Holm, S., & Hofmann, B. (Eds.), The Ethics of Research Biobanking (pp. 25-32). Springer. doi:10.1007/978-0-387-93872-1_2
25. Cassa, C. A. (2008). Privacy and identifiability in clinical research, personalized medicine, and public health surveillance: PhD thesis, Massachusetts Institute of Technology.
26. Caudill, E. M., & Murphy, P. E. (2000). Consumer Online Privacy: Legal and Ethical Issues. Journal of Public Policy & Marketing, 19(1), 7-19. doi:10.1509/jppm.19.1.7.16951
27. Cavoukian, A. (2009). Privacy by Design: Take the Challenge. Ontario, Canada: Information and Privacy Commissioner of Ontario.
28. Chalmers, D. (2007). International co-operation between biobanks: the case for harmonisation of guidelines and governance. In Stranger, M. (Ed.), Human Biotechnology & Public Trust: Trends, Perceptions and Regulation (pp. 237-246). Hobart: Centre for Law and Genetics.
29. Charo, R. A. (2007). Body of Research - Ownership and use of Human Tissue. The New England Journal of Medicine, 355, 1517-1519. doi:10.1056/NEJMp068192
30. Chen, J. Y., Yan, Z., Shen, C., Fitzpatrick, D. P., & Wang, M. (2007). A systems biology approach to the study of cisplatin drug resistance in ovarian cancers. Journal of Bioinformatics and Computational Biology, 5(2a), 383-405. doi:10.1142/S0219720007002606
31. Church, G. M. (2005). The personal genome project. Mol Syst Biol, 1, 2005 0030.
32. Collins, F. S., Green, E. D., Guttmacher, A. E., & Guyer, M. S. (2003). A vision for the future of genomics research. Nature, 422(6934), 835-847. doi:10.1038/nature01626
33. Conti, C., Veenstra, D.L., Armstrong, K., Lesko, J.L., & Grosse, S.D. (2010). (in press). Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost effectiveness, and future research priorities. Medical Decision Making. doi:10.1177/0272989X09347014
34. Culnan, M. J. (1993).How Did They Get My Name'? An Exploratory Investigation of Consumer Attitudes toward Secondary Information Use. Management Information Systems Quarterly, 17(3), 341-364. doi:10.2307/249775
35. Culnan, M. J. (1995). Consumer Awareness of Name Removal Procedures: Implication for Direct Marketing. Journal of Interactive Marketing, 9, 10-19.
36. Daikos, G. K. (2007). History of medicine: our Hippocratic heritage. International Journal of Antimicrobial Agents, 29(6), 617-620. doi:10.1016/j.ijantimicag.2007.01.008
37. Davis, R. (1995). Online medical records raise privacy fears. USA Today March 22.
38. Donaldson, T., & Dunfee, W. T. (1999). Ties that Bind: A Social Contracts Approach to Business Ethics. Cambridge, MA: Harvard Business School Press.
39. Elger, B. S., & Caplan, A. L. (2006). Consent and anonymization in research involving biobanks: Differing terms and norms present serious barriers to an international framework. EMBO Reports, 7(7), 661-666. doi:10.1038/sj.embor.7400740
40. Emanuel, E., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283(20), 2701-2711. doi:10.1001/jama.283.20.2701
41. Evans, B. J., Flockhart, D. A., & Meslin, E. M. (2004). Creating incentives for genomics research to improve targeting of therapies. Nature Medicine, 10, 1289-1291. doi:10.1038/nm1204-1289
42. Evans, B. J., &Meslin, E. M. (2006). Encouraging Translational Research Through Harmonization of FDA and Common-Rule Informed Consent Requirements for Research with Banked Specimens. Journal of Legal Medicine, 27, 119-166. doi:10.1080/01947640600716366
43. Foxman, E. R., & Kilcoyne, P. (1993). Information Technology, Marketing Practice, and Consumer Privacy: Ethical Issues. Journal of Public Policy & Marketing, 12(1), 106-119.
44. Fullerton, S. M., Anderson, N. R., Guzauskas, G., Freeman, D., & Fryer-Edwards, K. (2010). Meeting the Governance Challenges of NextGeneration Biorepository Research. Science Translational Medicine, 2(15), cm3. doi:10.1126/scitranslmed.3000361
45. Garrison, F. H. (1917). An Introduction to the History of Medicine (2nd ed.). Philadelphia: W.B. Saunders Company.
46. Gaudet, M., Fara, A. G., Beritognolo, I., & Sabatti, M. (2009). Allele-specific PCR in SNP genotyping. Methods in Molecular Biology (Clifton, N.J.), 578, 415-424. doi:10.1007/978-1-60327-411-1_26
47. Giacomini, K. M., Brett, C. M., Altman, R. B., Benowitz, N. L., Dolan, M. E., & Flockhart, D. A. (2007). The pharmacogenetics research network: from SNP discovery to clinical drug response. Clinical Pharmacology and Therapeutics, 81(3), 328-345. doi:10.1038/sj.clpt.6100087
48. Gilbert, M. T., Sanchez, J. J., Haselkorn, T., Jewell, L. D., Lucas, S. B., & Van Marck, E. (2007). Multiplex PCR with minisequencing as an effective high-throughput SNP typing method for formalin-fixed tissue. Electrophoresis, 28(14), 2361-2367. doi:10.1002/elps.200600589
49. Goldman, B. R., 4, 83. (2005). Pharmacogenomics: Privacy in the Era of Personalized Medicine. Northwestern Journal of Technology and Intellectual Property, 4(1), 140-143.
50. Goldman, R. E., Kingdon, C., Wasser, J., Clark, M. A., Goldberg, R., Papandonatos, G. D., et al. (2008). Rhode Islanders' attitudes towards the development of a statewide genetic biobank Personalized Medicine, 5(4), 339-359.
51. Goodman, K. W. (Ed.). (1998). Ethics, Computing and Medicine: Informatics and the Transformation of Health Care. New York: Cambridge University Press.
52. Goodman, K. W., & Miller, R. (2006). Ethics and Health Informatics: Users, Standards and Outcomes. In Shortliffe, E. H., Cimino, J., Garber, A. M., Owens, D. K., Singer, S. J., & Enthoven, A. C. (Eds.), Medical Informatics: Computer Applications in Health Care and Biomedicine (3rd ed., pp. 379-402). New York: Springer-Verlag.
53. Haas, D., Renbarger, J., Meslin, E. M., Drabiak, K., & Flockhart, D. (2008). Patient attitudes toward genotyping in an urban women's health clinic. Obstetrics and Gynecology, 112, 1023-1028. doi:10.1097/AOG.0b013e318187e77f
54. Habel, L. A., Shak, S., Jacobs, M. K., Capra, A., Alexander, C., & Pho, M. (2006). A populationbased study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Research, 8(3), R25. doi:10.1186/bcr1412
55. Harman, L. B. (2001). Ethical challenges in the management of health information (1 ed.): Aspen Pub.
56. Helft, P. R., Champion, V. L., Eckles, R., Johnson, C. S., & Meslin, E. M. (2007). Cancer patients' attitudes toward future research uses of stored human biological materials. Journal of Empirical Research on Human Research Ethics; JERHRE, 2(3), 15-22. doi:10.1525/jer.2007.2.3.15
57. Helgesson, G., & Swartling, U. (2008). Views on data use, confidentiality and consent in a predictive screening involving children. Journal of Medical Ethics, 34, 206-209. doi:10.1136/jme.2006.020016
58. Hobbs, M. S., & McCall, M. G. (1970). Health statistics and record linkage in Australia. Journal of Chronic Diseases, 23(5), 375-381. doi:10.1016/0021-9681(70)90020-2
59. Hodge, J. G., Gostin, L. O., & Jacobson, P. D. (1999). Legal Issues Concerning Electronic Health Information: Privacy, Quality, and Liability. Journal of the American Medical Association, 282(15), 1466-1471. doi:10.1001/jama.282.15.1466
60. Holman, C.D.J., Bass, A.J., Rouse, I.L., & Hobbs, M.S.T. (1999). Population-based linkage of health records in Western Australia: development of a health services research linked database. Australian and New Zealand Journal of Public Health, 23, 453-459. doi:10.1111/j.1467-842X.1999.tb01297.x
61. Holtzman, N. A., & Watson, M. S. (Eds.). (1998). Promoting safe and effective genetic testing in the United States: final report of the task force on genetic testing. Baltimore: Johns Hopkins University Press.
62. Homer, N., Szelinger, S., Redman, M., Duggan, D., Tembe, W., & Muehling, J. (2008). Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLOS Genetics, 4(8), e1000167. doi:10.1371/journal.pgen.1000167
63. Hood, L., Heath, J. R., Phelps, M. E., & Lin, B. (2004). Systems biology and new technologies enable predictive and preventative medicine. Science, 306(5696), 640-643. doi:10.1126/science.1104635
64. Huan, T., Wu, X., & Chen, J. Y. (2010). (in press). Systems Biology Visualization Tools for Drug Target Discovery. Expert Opinion on Drug Discovery. doi:10.1517/17460441003725102
65. Humgen. (2010). http://www.humgen.org/int/GB2_p.cfm?mod=1.
66. IOM. (2001). Preserving public trust: accreditation and human research participant protection programs. Washington, DC: Institute of Medicine.
67. Kalichman, M. (2007). Responding to challenges in educating for responsible conduct of research. Academic Medicine, 82, 870-875. doi:10.1097/ACM.0b013e31812f77fe
68. Kaye, J., & Stranger, M. (Eds.). (2009). Principles and Practice in Biobank Governance. Surrey, UK: Ashgate.
69. Kelman, C.W., Bass, A. J., & Holman, C. D. (2002). Research use of linked health data--a best practice protocol. Australian and New Zealand Journal of Public Health, 26, 251-255. doi:10.1111/j.1467-842X.2002.tb00682.x
70. Kitano, H. (2002). Systems biology: a brief overview. Science, 295(5560), 1662-1664. doi:10.1126/science.1069492
71. Klein, T. E., Altman, R. B., Eriksson, N., Gage, B. F., Kimmel, S. E., & Lee, M. T. (2009). Estimation of the warfarin dose with clinical and pharmacogenetic data. The New England Journal of Medicine, 360(8), 753-764. doi:10.1056/NEJMoa0809329
72. Klopfer, P. H., & Rubenstein, D. L. (1977). The concept privacy and its biological basis. The Journal of Social Issues, 33, 52-65. doi:10.1111/j.1540-4560.1977.tb01882.x
73. Knoppers, B. M. (2005). Consent revisited: points to consider. Health Law Review, 13(2/3), 33-38.
74. Knoppers, B. M., & Saginur, M. (2005). The Babel of genetic data terminology. Nature Biotechnology, 23(8), 925-927. doi:10.1038/nbt0805-925
75. Korkko, J., Milunsky, J., Prockop, D. J., & AlaKokko, L. (1998). Use of conformation sensitive gel electrophoresis to detect single-base changes in the gene for COL10A1. Human Mutation, (Suppl 1), S201-S203.
76. Kricka, L. J., Master, S. R., Joos, T. O., & Fortina, P. (2006). Current perspectives in protein array technology. Annals of Clinical Biochemistry, 43(Pt 6), 457-467. doi:10.1258/000456306778904731
77. Kwok, P. Y., & Duan, S. (2003). SNP discovery by direct DNAsequencing. Methods in Molecular Biology (Clifton, N.J.), 212, 71-84.
78. Lasko, T. A., & Vinterbo, S. A. (2010). Spectral Anonymization of Data. IEEE Transactions on Knowledge and Data Engineering, 22(3), 437-446. doi:10.1109/TKDE.2009.88
79. Laufer, R. S., & Wolfe, M. (1977). Privacy as a Concept and a Social Issue - Multidimensional Developmental Theory. The Journal of Social Issues, 33(3), 22-42. doi:10.1111/j.1540-4560.1977.tb01880.x
80. Leiman, D. A., Lorenzi, N. M., Wyatt, J. C., Doney, A. S. F., & Rosenbloom, S. T. (2008). US and Scottish Health Professionals' Attitudes toward DNABiobanking. Journal of the American Medical Informatics Association, 15(3), 357-362. doi:10.1197/jamia.M2571
81. Lesko, L. J., Salerno, R. A., Spear, B. B., Anderson, D. C., Anderson, T., & Brazell, C. (2003). Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: Report of the first FDA-PWG-PhRMA-DruSafe Workshop. Journal of Clinical Pharmacology, 43, 342-358. doi:10.1177/0091270003252244
82. Lin, Z., Owen, A. B., & Altman, R. B. (2004). GENETICS: Genomic Research and Human Subject Privacy. Science, 305(5681), 183. doi:10.1126/science.1095019
83. Lunshof, J. E., Chadwick, R., Vorhaus, D. B., & Church, G. M. (2008). From genetic privacy to open consent. Nature Reviews. Genetics, 9(5), 406-411. doi:10.1038/nrg2360
84. Machanavajjhala, A., Kifer, D., Gehrke, J., & Venkitasubramaniam, M. (2007). L-diversity: Privacy beyond k-anonymity. ACM Trans. Knowl. Discov. Data, 1(1), 3. doi:10.1145/1217299.1217302
85. Malin, B. A., & Sweeney, L. (2004). How (not) to protect genomic data privacy in a distributed network: using trail re-identification to evaluate and design anonymity protection systems. Journal of Biomedical Informatics, 37(3), 179-192. doi:10.1016/j.jbi.2004.04.005
86. Marks, A. D., & Steinberg, K. K. (2002). The Ethics of Access to Online Genetic Databases: Private or Public? American Journal of Pharmacogenomics, 2, 207-212. doi:10.2165/00129785-200202030-00006
87. Marx, G. T. (1999). What's in a name? Some reflections on the sociology of anonymity. [Article]. The Information Society, 15(2), 99-112. doi:10.1080/019722499128565
88. Meslin, E. M. (2010). The Value of Using TopDown and Bottom-Up Approaches for Building Trust and Transparency in Biobanking. Public Health Genomics, 13(4).
89. Meslin, E. M., & Goodman, K. W. (2010).An Ethics and PolicyAgenda for Biobanks and Electronic Health. Science Progress, February 25th, http://www.scienceprogress.org/2010/2002/bank-on-it/.
90. Meslin, E. M., & Quaid, K. A. (2004). Ethical Issues in the Storage, Collection and Research Use of Human Biological Materials. The Journal of Laboratory and Clinical Medicine, 144, 229-234. doi:10.1016/j.lab.2004.08.003
91. Murphy, J., Scott, J., Kaufman, D., Geller, G., LeRoy, L., & Hudson, K. (2009). Public Perspectives on Informed Consent for Biobanking. American Journal of Public Health, 99(12), 2128-2134. doi:10.2105/AJPH.2008.157099
92. Naylor, S., & Chen, J. Y. (2010). Unraveling Human Complexity and Disease with Systems Biology and Personalized Medicine. Personalized Medicine, 7(3), 275-289. doi:10.2217/pme.10.16
93. NBAC. (1999). Research involving human biological materials: ethical issues and policy guidance, vol I: report and recommendations. Bethesda, MD: National Bioethics Advisory Commission.
94. NBAC. (2001). Ethical and Policy Issues in Research Involving Human Participants. Bethesda, MD: National Bioethics Advisory Commission.
95. Nicol, D., & Critchley, C. (2009). What Benefit Sharing Arrangements Do People Want From Biobanks? A Survey of Public Opinion in Australia. In Kaye, J., & Stranger, M. (Eds.), Principles and Practice in Biobank Governance (pp. 17-31). Surrey, UK: Ashgate.
96. Norton, P. G., Bain, J., Birtwhistle, R., Davis, D., & Dunn, E. CP, H., et al. (1994). Guidelines for the Dissemination of New Information Discovered by Researchers. In M. A. Stewart, P. G. Norton, M. Bass, E. Dunn & F. Tudiver (Eds.), Disseminating Research/Changing Practice. Research Methods for Primary Care (Vol. 6, pp. 87-94). Thousand Oaks, CA: Sage Publications.
97. Palsson, B. (2002). In silico biology through "omics". Nature Biotechnology, 20(7), 649-650. doi:10.1038/nbt0702-649
98. Palsson, B. (2006). Systems biology: properties of reconstructed networks. Cambridge, New York: Cambridge University Press. doi:10.1017/CBO9780511790515
99. Pellegrino, E. D., & Thomasma, D. C. (1984). For the Patient's Good: The Restoration of Beneficence in Health Care. New York: Oxford.
100. Plant, N. (2007). The human cytochrome P450 subfamily: transcriptional regulation, inter-individual variation and interaction networks. Biochimica et Biophysica Acta, 1770(3), 478-488.
101. Project, H. G. (2010). Human Genome Project: www.ornl.gov/hgmis/home.shtml.
102. Pusch, W.,Wurmbach, J. H., Thiele, H., &Kostrzewa, M. (2002). MALDI-TOF mass spectrometrybased SNP genotyping. Pharmacogenomics, 3(4), 537-548. doi:10.1517/14622416.3.4.537
103. Ramsey, P. (1960). For the Patient's Good. Princeton University Press.
104. Robertson, J. A. (2001). Consent and privacy in pharmacogenetic testing. Nature Genetics, 28(3), 207-209. doi:10.1038/90032
105. Ronaghi, M. (2003). Pyrosequencing for SNP genotyping. Methods in Molecular Biology (Clifton, N.J.), 212, 189-195.
106. Rothstein, M. A., & Epps, P. G. (2001). Ethical and legal implications of pharmacogenomics. Nature Reviews. Genetics, 2(3), 228-231. doi:10.1038/35056075
107. Saha, S., Harrison, S. H., & Chen, J. Y. (2009). Dissecting the human plasma proteome and inflammatory response biomarkers. Proteomics, 9(2), 470-484. doi:10.1002/pmic.200800507
108. Saha, S., Harrison, S. H., Shen, C., Tang, H., Radivojac, P., & Arnold, R. J. (2008). HIP2: An online database of human plasma proteins from healthy individuals. BMC Medical Genomics, 1, 12. doi:10.1186/1755-8794-1-12
109. Schoeman, F. D. (1984). Philosophical Dimensions of Privacy: an Anthology. Cambridge, New York: Cambridge University Press. doi:10.1017/CBO9780511625138
110. Schwartz, P. H., & Meslin, E. M. (2008). The Ethics of Information: Absolute Risk Reduction and Patient Understanding of Screening. Journal of General Internal Medicine.
111. Shapero, M. H., Leuther, K. K., Nguyen, A., Scott, M., & Jones, K. W. (2001). SNP genotyping by multiplexed solid-phase amplification and fluorescent minisequencing. Genome Research, 11(11), 1926-1934.
112. Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., & Smigielski, E. M. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Research, 29(1), 308-311. doi:10.1093/nar/29.1.308
113. Stanley, F. J., Croft, M. L., Gibbins, J., & Read, A. W. (2008). A population database for maternal and child health research in Western Australia using record linkage. Paediatric and Perinatal Epidemiology, 8(4), 433-447. doi:10.1111/j.1365-3016.1994.tb00482.x
114. Stanley, F. J., & Meslin, E., M. (2007). Australia Needs a Better System for Health Care Evaluation. The Medical Journal of Australia, 186, 220-221.
115. Suh, Y., & Vijg, J. (2005). SNP discovery in associating genetic variation with human disease phenotypes. Mutation Research, 573(1-2), 41-53. doi:10.1016/j.mrfmmm.2005.01.005
116. Sweeney, L., & Sweeney, L. (2002). Achieving K-Anonymity Privacy Protection Using Generalization and Suppression. International Journal on Uncertainty, Fuzziness and Knowledge-based Systems, 10, 2002.
117. Tahira, T., Suzuki, A., Kukita, Y., & Hayashi, K. (2003). SNP detection and allele frequency determination by SSCP. Methods in Molecular Biology (Clifton, N.J.), 212, 37-46.
118. Tang, Z., Hu, Y. J., & Smith, M. D. (2008). Gaining Trust Through Online Privacy Protection: Self-Regulation, Mandatory Standards, or Caveat Emptor. Journal of Management Information Systems, 24(4), 153-173. doi:10.2753/MIS0742-1222240406
119. Tchabo, N. E., Liel, M. S., & Kohn, E. C. (2005). Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer. American Journal of Pharmacogenomics, 5(3), 141-148. doi:10.2165/00129785-200505030-00001
120. Tefft, S. K. (1980). Secrecy, a Cross-Cultural Perspective. NewYork, N.Y.: Human Sciences Press.
121. Trutwein, B., Holman, C. D., & Rosman, D. L. (2006). Health data linkage conserves privacy in a research-rich environment. Annals of Epidemiology, 16(4), 279-280. doi:10.1016/j.annepi-dem.2005.05.003
122. Turner, C. E., & Dasgupta, S. (2003). Privacy on the Web: An Examination of User Concerns, Technology, and Implications for Business Organizations and Individuals. Information Systems Management, (Winter): 8-18. doi:10.1201/1078/43203.20.1.20031201/40079.2
123. Twyman, R. M. (2004). SNP discovery and typing technologies for pharmacogenomics. Current Topics in Medicinal Chemistry, 4(13), 1423-1431. doi:10.2174/1568026043387656
124. Vasgird, D. (2007). Prevention Over Cure: The Administrative Rationale for Education in the Responsible Conduct of Research. Academic Medicine, 82, 835-837. doi:10.1097/ACM.0b013e31812f7e0b
125. Vaszar, L. T., Cho, M. K., & Raffin, T. A. (2003). Privacy issues in personalized medicine. Pharmacogenomics, 4(2), 107-112. doi:10.1517/phgs.4.2.107.22625
126. Veatch, R. M. (1981). A Theory of Medical Ethics. New York: Basic Books.
127. Visscher, P. M., & Hill, W. G. (2009). The limits of individual identification from sample allele frequencies: theory and statistical analysis. PLOS Genetics, 5(10), e1000628. doi:10.1371/journal.pgen.1000628
128. Warren, S. D., & Brandeis, D. L. (1890). The Right to Privacy. Harvard Law Review, 4(5), 193-220. doi:10.2307/1321160
129. Weir, R. F., & Horton, J. R. (1995). DNA banking and informed consent -- part 2. IRB, 17(5-6), 1-8.
130. Westin, A. F. (1967). Privacy and Freedom. New York: Atheneum.
131. Wolf, V. A. d., Sieber, J. E., Steel, P. M., & Zarate, A. O. (2005). Part I: What Is the Requirement for Data Sharing? IRB: Ethics and Human Research, 27(6), 12-16. doi:10.2307/3563537
132. Wolford, J. K., Blunt, D., Ballecer, C., & Prochazka, M. (2000). High-throughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC). Human Genetics, 107(5), 483-487. doi:10.1007/s004390000396
133. Xu, H., Teo, H. H., Tan, B. C. Y., & Agarwal, R. (2010). The Role of Push-Pull Technology in Privacy Calculus: The Case of Location-Based Services. Journal of Management Information Systems, 26(3), 137-176.
134. Zwick, D., & Dholakia, N. (2004). Whose Identity Is It Anyway? Consumer Representation in the Age of Database Marketing. Journal of Macromarketing, 24(1), 31-43. doi:10.1177/0276146704263920